Monday, February 13, 2017 3:10:46 PM
Also in PSIX As a bottom Play
Recent DARE News
- Positive Interim Phase 3 Results Highlight Potential of Ovaprene®, Novel Hormone-Free Contraceptive • GlobeNewswire Inc. • 05/12/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2026 08:11:05 PM
- Daré Bioscience to Host First Quarter 2026 Financial Results and Company Update Conference Call and Webcast on May 14, 2026 • GlobeNewswire Inc. • 05/07/2026 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/28/2026 08:40:46 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/28/2026 08:33:21 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/28/2026 08:02:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/22/2026 01:00:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/20/2026 08:07:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/17/2026 08:10:22 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 04/17/2026 08:04:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/13/2026 08:58:43 PM
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 04/02/2026 04:15:02 AM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/26/2026 08:02:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 08:01:23 PM
- Daré Bioscience Reports Full Year 2025 Financial Results and Provides Business Update • GlobeNewswire Inc. • 03/26/2026 08:01:00 PM
- On National Viagra Day, Women Finally Claim Their Turn: • GlobeNewswire Inc. • 03/23/2026 12:00:00 PM
- Daré Bioscience to Host Full Year 2025 Financial Results and Company Update Conference Call and Webcast on March 26, 2026 • GlobeNewswire Inc. • 03/20/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/17/2026 08:37:30 PM
- Dare Bioscience secures NIH funding extension for preterm birth therapy • IH Market News • 03/16/2026 02:29:18 PM
- Daré Bioscience Receives NIH Funding Award Notice to Advance DARE-PTB1, its Novel Intravaginal Ring for Prevention of Preterm Birth • GlobeNewswire Inc. • 03/16/2026 12:00:00 PM
- Daré Bioscience Participates in Virtual Investor “What This Means” Segment • GlobeNewswire Inc. • 03/12/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/09/2026 08:05:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/02/2026 01:01:21 PM
- Daré Bioscience Announces FDA Clearance of IND for Phase 2 Clinical Study of DARE-HPV, a Potential Treatment for Persistent High-Risk HPV Infection, the Most Common Cause of Cervical Cancer • GlobeNewswire Inc. • 02/23/2026 01:00:00 PM
- Telehealth Now Available for DARE to PLAY™ Sildenafil Cream: First Evidence-Based Topical Arousal Cream for Women • GlobeNewswire Inc. • 02/11/2026 01:00:00 PM
